In addition to the prostate cancer cell lines, we also evaluated MCF-7 breast cancer cells, since it has been shown that TWIST1/N-cadherin signaling is deficient in MCF-7 cancer cells [19, 20]. The gene discussed is CDH2; the disease is prostate carcinoma.